Hot app: Boston Children's Feverprints boosts understanding of body temp patterns

The Innovation & Digital Health Accelerator (IDHA) and Autoinflammatory Diseases Clinic at Boston Children's Hospital have released Feverprints, a ResearchKit app for iPhone that will enlist the public's help to determine what, exactly, is a fever.

The question is "surprisingly simple but fundamental," according to the organization.

Fever is one of the most common signs of infection, but can also indicate the presence of other medical conditions, including autoimmune and autoinflammatory diseases. While a body temperature of 98.6°F is generally considered "normal," this number may not be accurate, as it does not account for temperature differences between individuals, and for one person at various times throughout the day. Better understanding of normal temperature variations will allow doctors to provide better medical care. By using ResearchKit, an open source software framework designed by Apple, Boston Children’s Hospital is able to gather data more frequently and more accurately from participants using an iPhone.

"Many factors come together to set an individual's 'normal' temperature, such as age, size, time of day and maybe even ancestry," said Jared Hawkins, MMSc, PhD, the director of informatics for IDHA, a member of Boson Children's Computational Health Informatics Program, and one of the Feverprints team leads. "We want to help create a better understanding of the normal temperature variations throughout the day, to learn to use fever as a tool to improve medical diagnosis, and to evaluate the effect of fever medications on symptoms and disease course. By using ResearchKit to bring this study to iPhone, we’re able to gather more data about body temperature patterns than ever before possible."

The Feverprints app will help answer those questions by crowdsourcing personal information about body temperature, lifestyle and health. Open to adults in the U.S., as well as U.S. children with parental consent, the app will regularly remind users to record their temperature and answer questions about their symptoms, medications, lifestyle and health. The data will be anonymized and logged in a secure database.

The team—led by Fatma Dedeoglu, MD, director of the Autoinflammatory Diseases Clinic, and Boston Children's rheumatologist Jonathan Hausmann, MD—will mine the submitted data to refine the range of body temperatures called normal and febrile. They will also use the data to define unique patterns of temperature—"feverprints"—that may help clinicians diagnose infections and other diseases more quickly and accurately. In addition, the team will systematically examine how effectively fever-reducing medicines work to reduce temperature in real-world use.

Feverprints is Boston Children's second ResearchKit app. The first, C-Tracker, was launched in 2015 to gather information about the real-world impacts of hepatitis C and drive improvements in treatment.

Feverprints is free and available for download in the App Store.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.